Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Tesamorelin vs CJC-1295: FDA GHRH vs Research

Tesamorelin vs CJC-1295: FDA GHRH (-18% visceral fat, Phase III) vs research peptide (2-10x GH, Phase I). Cost, dosing, and who picks which.

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Tesamorelin vs CJC-1295: FDA GHRH (-18% visceral fat, Phase III) vs research peptide (2-10x GH, Phase I). Cost, dosing, and who picks which.